"When it comes to urban living, keeping things clean is crucial. But not everyone follows the same rules. Some countries have launched projects to change how people act, hoping it'll make cities cleaner. But do these projects really work? Well, the answer isn't clear yet. Researchers have looked int
Imagine running the 100m race a hundred years apart. That's what Noah Lyles and Harold Abrahams did. Lyles, the 27-year-old Olympic champion, clocked 9. 79 seconds in the 2024 Paris Olympics. Abrahams, from the 1924 Games, ran the same distance in 10. 6 seconds. That's a difference of 0. 81 seconds,
Kyle Busch, a legendary NASCAR driver, had a rough season in 2024 with no wins and a disappointing 20th place. So, he decided to switch things up and try something new: dirt racing. Fans were stunned when he entered the 2025 Tulsa Shootout, known for its micro-midget races. Busch's performance was i
You might think that a lot of U. S. teens are getting gender-affirming medications, right? Well, a recent study says that's not the case. In fact, less than 1 in 1, 000 adolescents with commercial insurance received these medications over a five-year period. This includes puberty blockers and hormon
For a long time, the parable of the Prodigal Son has been mostly focused on men like the father and the sons. But what if we look at it differently? Some historians think that the original listeners might have seen two important women in the story: the mother of the Prodigal Son and the mother of th
Imagine you're battling advanced biliary tract cancer (ABTC), and your doctors suggest a mix of drugs: nivolumab, modified gemcitabine, and S-1. This combo showed promise in a past trial, but PD-L1 levels didn't tell us much about how well it would work. So, scientists looked at another marker, LAG-
You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has
Immune treatments, or immune checkpoint inhibitors (ICIs), are game-changers for some people with far-advanced solid tumors. But when it comes to biliary tract cancer (BTC), doctors are still figuring out who gets the most benefit from these treatments. A recent trial focused on pembrolizumab, an IC
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
Science fiction films have long used aliens to explore real-world topics like immigration. After the Cold War, Hollywood and other countries' films started to reflect more on race, class, and gender in relation to immigration. By looking at movies like Alien Nation, Coneheads, Men in Black, the Star
